Doximity (Doximity) Capex-to-Revenue : 0.01 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Doximity Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Doximity's Capital Expenditure for the three months ended in Dec. 2023 was $-1.32 Mil. Its Revenue for the three months ended in Dec. 2023 was $135.28 Mil.

Hence, Doximity's Capex-to-Revenue for the three months ended in Dec. 2023 was 0.01.

Doximity Capex-to-Revenue Historical Data

The historical data trend for Doximity's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Doximity Capex-to-Revenue Chart

Doximity Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Capex-to-Revenue

0.01

0.04

0.02

Doximity Quarterly Data
	Mar19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Capex-to-Revenue	Get a 7-Day Free Trial												0.01	0.01	0.01	0.01	0.01

Competitive Comparison of Doximity's Capex-to-Revenue

For the Health Information Services subindustry, Doximity's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Doximity's Capex-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Doximity's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Doximity's Capex-to-Revenue falls into.

Doximity Capex-to-Revenue Calculation

Doximity's Capex-to-Revenue for the fiscal year that ended in Mar. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-6.184)	/	419.052
	=	0.01

Doximity's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-1.324)	/	135.284
	=	0.01

Doximity (NYSE:DOCS) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Doximity Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Doximity's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Doximity (Doximity) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Doximity Inc (NYSE:DOCS) » Definitions » Capex-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 3rd Street, Suite 510, San Francisco, CA, USA, 94107

Website

https://www.doximity.com

Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.

Executives

Kira Scherer Wampler	director	C/O DOXIMITY, INC., 500 3RD STREET, SUITE 510, SAN FRANCISCO CA 94107
Craig Overpeck	officer: See Remarks	C/O DOXIMITY, INC., 500 THIRD STREET, SUITE 510, SAN FRANCISCO CA 94107
Timothy S Cabral	director	C/O VEEVA SYSTEMS INC., 4280 HACIENDA DRIVE, PLEASANTON CA 94588
Anna Bryson	officer: Chief Financial Officer	C/O DOXIMITY, INC., 500 3RD STREET SUITE 510, SAN FRANCISCO CA 94107
Yang Watkin Phoebe L.	director	C/O DOXIMITY, INC., 500 THIRD STREET, SAN FRANCISCO CA 94107
Jeffrey Tangney	director, 10 percent owner, officer: Chief Executive Officer	C/O DOXIMITY, INC., 500 3RD STREET SUITE 510, SAN FRANCISCO CA 94107
Paul W. Jorgensen	officer: Chief Revenue Officer	500 THIRD STREET, SUITE 510, SAN FRANCISCO CA 94107
Gilbert H Kliman	director, 10 percent owner	C/O INTERWEST PARTNERS, 467 FIRST STREET SUITE 201, LOS ALTOS CA 94022
Emergence Capital Partners Ii Lp	10 percent owner	160 BOVET ROAD, SAN MATEO CA 94402
Emergence Equity Partners Ii, L.p.	10 percent owner	160 BOVET ROAD, SUITE 300, SAN MATEO CA 94402
Emergence Gp Partners, Llc	10 percent owner	PIER 5, THE EMBARCADERO, STE 102, SAN FRANCISCO CA 94111-2094
Kevin Spain	director	C/O EMERGENCE CAPITAL, 160 BOVET ROAD, STE. 300, SAN MATEO CA 94402
Emergence Capital Opportunity I, L.p.	10 percent owner	160 BOVET ROAD, SUITE 300, SAN MATEO CA 94402
Emergence Equity Partners Vi, L.p.	10 percent owner	C/O EMERGENCE CAPITAL PARTNERS, 160 BOVET ROAD, SUITE 300 CA SAN MATEO
Regina M. Benjamin	director	51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453